WAM
TMO icon

Wolverine Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Wolverine Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
2,900
+1,000
+53% +$480K 0.01% 699
2026
Q1 		$934K Sell
1,900
-2,000
-51% -$1.09M 0.01% 798
2025
Q4 		$2.26M Sell
3,900
-4,100
-51% -$2.32M 0.02% 568
2025
Q3 		$3.88M Sell
8,000
-9,400
-54% -$4.38M 0.03% 412
2025
Q2 		$7.06M Buy
17,400
+13,300
+324% +$5.56M 0.07% 273
2025
Q1 		$2.04M Sell
4,100
-38,000
-90% -$20.6M 0.02% 511
2024
Q4 		$21.9M Sell
42,100
-25,700
-38% -$14.1M 0.22% 117
2024
Q3 		$41.9M Sell
67,800
-5,300
-7% -$3.14M 0.45% 57
2024
Q2 		$40.4M Buy
73,100
+49,400
+208% +$28.3M 0.46% 52
2024
Q1 		$13.8M Sell
23,700
-20,300
-46% -$11.4M 0.16% 146
2023
Q4 		$23.4M Buy
44,000
+23,100
+111% +$11.2M 0.2% 126
2023
Q3 		$10.6M Buy
20,900
+11,800
+130% +$6.29M 0.12% 189
2023
Q2 		$4.75M Sell
9,100
-4,200
-32% -$2.27M 0.06% 307
2023
Q1 		$7.67M Buy
13,300
+3,300
+33% +$1.86M 0.09% 246
2022
Q4 		$5.51M Buy
10,000
+8,400
+525% +$4.45M 0.06% 312
2022
Q3 		$811K Buy
+1,600
New +$895K 0.01% 852
2016
Q1 		– Sell
-239
Closed -$70K – 1616
2015
Q4 		$70K Buy
239
+100
+72% +$13.3K ﹤0.01% 1069
2015
Q3 		$160K Hold
139
– – ﹤0.01% 971
2015
Q2 		$125K Hold
139
– – ﹤0.01% 1054
2015
Q1 		$120K Sell
139
-4
-3% -$516 ﹤0.01% 1016
2014
Q4 		$35K Buy
143
+75
+110% +$9.12K ﹤0.01% 1497
2014
Q3 		$8K Sell
68
-4
-6% -$486 ﹤0.01% 2046
2014
Q2 		$25K Buy
72
+19
+36% +$2.24K ﹤0.01% 1641
2014
Q1 		$22K Buy
+53
New +$6.3K ﹤0.01% 1613
2013
Q4 		– Sell
-26
Closed -$2K – 2933
2013
Q3 		$2K Sell
26
-24
-48% -$2.17K ﹤0.01% 2541
2013
Q2 		$19K Buy
+50
New +$4.16K ﹤0.01% 2028

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wolverine Asset Management's TMO Position: Q2 2026 in Review

Wolverine Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 77% in Q2 2026, selling an estimated $305K and leaving 188 shares worth $94.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1176.

Wolverine Asset Management first reported a position in TMO in Q1 2014 and has held it in 19 quarters since. The position peaked at $10.5M in Q2 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Wolverine Asset Management held 188 shares of Thermo Fisher Scientific worth $94.3K as of Q2 2026.
  • Wolverine Asset Management sold 635 Thermo Fisher Scientific shares in Q2 2026, an estimated $305K.
  • Thermo Fisher Scientific made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1176 holding.
  • Wolverine Asset Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 19 quarters since.
  • Wolverine Asset Management's Thermo Fisher Scientific position peaked at $10.5M in Q2 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.